Back to News
Relay Therapeutics joins IQ Consortium
March 31, 2022
The IQ Consortium is pleased to announce its newest member, Relay Therapeutics, a clinical-stage precision medicine company that sits at the intersection of computational and experimental technologies.
Relay Therapeutics will be represented on the IQ Board of Directors by Mahesh Padval.